Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? - authors' reply
- PMID: 24849857
- PMCID: PMC9242618
- DOI: 10.1016/S1474-4422(14)70097-3
Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? - authors' reply
Conflict of interest statement
We declare that we have no competing interests.
Comment on
-
Outcome markers for clinical trials in cerebral amyloid angiopathy.Lancet Neurol. 2014 Apr;13(4):419-28. doi: 10.1016/S1474-4422(14)70003-1. Epub 2014 Feb 27. Lancet Neurol. 2014. PMID: 24581702 Free PMC article. Review.
-
Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise?Lancet Neurol. 2014 Jun;13(6):538-40. doi: 10.1016/S1474-4422(14)70096-1. Lancet Neurol. 2014. PMID: 24849855 No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
